p<0,05). By the use of binary regression analysis with the building of ROC-curves we established the values of these STE parameters, obtained within the 1st month after myocarditis onset, that could be considered as predictors of persistent LV systolic dysfunction after 1 year of follow-up: LGSS <8,6% (sensitivity -76%, specificity 72%), LGSSr <0,63 s -1 (sensitivity -72%, specificity 78%), CGSS <8,3% (sensitivity -80%, specificity 66%). Conclusion: We detected STE parameters that within the 1st month after myocarditis onset could be used for prognostication of LV systolic dysfunction persistence after 1 year of follow-up: values of LGSS, LGSSr and CGSS.
P3513 | BEDSIDE Approximation of true incidence of myocarditis by systematic screening of patients with cardiac magnetic resonance imaging after exclusion of significant coronary artery disease D. Patriki, E.G. Gresser, R.M. Manka, T.L. Luescher, B.H. Heidecker. University Heart Center, Zurich, Switzerland Background: Underdiagnosis of myocarditis remains a clinical dilemma and its incidence remains uncertain. Postmortem data have implicated myocarditis in sudden cardiac death at a rate up to 12%, suggesting a considerable number of cases who remain undiagnosed and untreated. We sought to test the hypothesis that systematic screening of patients presenting with angina-like symptoms, elevated high sensitivity troponin T (TnT-hs, ≥14ng/l) and no significant coronary artery disease, by using cardiac magnetic resonance imaging (CMR), will provide an approximation of the true incidence of myocarditis at our hospital. Methods: We performed a retrospective chart review of all patients, who presented with angina-like symptoms and elevated TnT-hs in the years 2015 and 2016. During the year 2015, patients with moderate to high clinical suspicion for myocarditis underwent CMR. Starting 2016, CMR was obtained in all patients based on criteria above independent of degree of clinical suspicion for myocarditis. To assess the increase in incidence of myocarditis detected through aggressive screening in 2016, we compared it to the incidence in 2015, when the threshold for screening was still higher. Results: A total of 2889 patients (77% male, 66±15 years) qualified for our chart review. Among the most common diagnoses on CMR were myocarditis (8%) and hypertrophic cardiomyopathy (4%), while 35% of CMR studies were unremarkable. Fourteen patients did not undergo CMR at our hospital due to contraindications, claustrophobia or hospital transfer. In the first year, 1001 patients presented to our hospital with angina-like symptoms and TnT-hs elevation, in the year thereafter it were 1888 patients. In the year 2015, the number of CMR studies was 99 with a subsequent increase to 215 in the year 2016. While in the year 2015, only 4 cases were identified with myocarditis, the number increased 6-fold to a total of 24 in the year 2016 (p-value=0.04). Conclusion: This is the first study to assess the incidence of myocarditis by systematic screening with CMR in patients with angina-like symptoms, elevated TnT-hs and negative coronary angiography. Our data support the hypothesis that myocarditis continues to be an underdiagnosed illness and its incidence is currently strongly underestimated. Given the potentially severe adverse outcomes of myocarditis if left untreated, including malignant arrhythmias and heart failure secondary to chronic inflammation, we recommend a low threshold for the use of CMR. Introduction: The diagnosis of acute myocarditis (aMyo) needs a high level of suspicion. Cardiac magnetic resonance (CMR) may contribute to the diagnosis; but endomyocardial biopsy (EMB) is considered the gold standard, although used infrequently worldwide. Short-term course, albeit unpredictable is usually benign and treatment is mainly supportive. Objectives: To assess the usual care attitudes regarding hospitalized patients (pts) with a diagnosis of aMyo in Portugal, report patient's clinical profiles and current therapeutic approaches, and assess the relevance of CMR to eventual changes in management and/or therapeutic decisions. Methods: Prospective nationwide survey of admitted aMyo pts during a 2-year period (25.04.13-15). Electronic CRFs were completed with admission/discharge data, diagnostic tests, treatments and open-ended questions to evaluate physician's opinions and conclusions. Results: 248 pts from 18 centers were included, 98% caucasian, 35±14 (18-84) years old, 83% male. A recent infectious disease was detected in 57.5% (upper respiratory tract in 71.2%) and 23% had been previously treated with antibiotics. On admission, presentation included angina-like thoracic pain (96%), non-CV symptoms-58.4% (fever-71%, respiratory-52.8%, GI-28.1%), heart failure (HF)-5.4% and cardiogenic shock-0.8%; abnormal ECG -82% (mostly ST elevation-78.5%); increased troponin levels in 95%; echo (in 94%pts) showed left ventricular dilatation (LVD) -5.7%, segmental LV wall abnormalities (segmAbn) -34%, reduced LV ejection fraction (RLVEF) -21% and pericardial effusion (PE) -11.7%. CMR (in 57%pts), didn't change the management in 70% of cases. Coronary angiography (in 40%) revealed significant CAD in 7.4%. EMB was diagnostic in the 2 pts in which was performed (due to severe progressive HF). Multiple viral serologies (in 32.4% pts) were conclusive in only 0.5%. Most pts were treated with NSAIDs, 39% received ACEi or ARB, 36% a beta-blocker (BB) and 8.4% diuretics; 3.4% needed inotropes. Only 1 death occurred (shock). At discharge, an abnormal ECG persisted in 64.4% of pts; echo (in 50.4%) showed LVD in 6%, segmAbn in 24.6%, RLVEF in 14.6% and PE in 10.2%. Most pts (88.2%) were discharged on NSAIDs, 37.6% on ACEi or ARB, 30.36% on BB, and 6.47% on diuretics. Background: Endomyocardial biopsy (EMB) represents the gold standard technique for the diagnosis of inflammatory cardiomyopathy (ICMP). According to some authors, its sensitivity is significantly improved when EMB is guided by late gadolinium enhancement (LGE) at cardiac magnetic resonance (CMR) or by electro-anatomical mapping (EAM). However, these procedures are often complex and time-consuming. Moreover, the risk of complications increases, as far as EMB is performed away from the right ventricular septum (RVS), which is the simplest and safest area to sample.
P3514 | BEDSIDE Diagnosis and treatment of acute myocarditis in Portugal. Data from the national multicenter registry on myocarditis
Purpose: We show that, in patients with clinically suspect ICMP, performing an EMB by sampling the RVS only, is accurate enough to reach a diagnosis, despite of the presence of locally abnormal signals at CMR or EAM. Methods: We analysed 87 patients with the clinical suspicion of ICM. All of them had evidence of normal coronary arteries and underwent both CMR and EMB. EMB was performed percutaneously via trans-jugular access, guided by fluoroscopy and trans-thoracic echocardiogram. Five samples of myocardium were obtained from RVS in all of the patients, wherever LGE was found at CMR. Histopathological results were compared with CMR findings. In patients presenting with ventricular arrhythmias and indication to substrate ablation, EAM was also available for comparison. Results: Overall, 62 patients (71.3%) had a histopathological diagnosis of ICMP, while 15 (17.2%) had a different but defined diagnosis. Nonspecific EMB was found in 10 patients only (11.5%), with CMR suggesting a defined diagnosis in 5/10 cases. CMR showed LGE in 75/87 cases (86.2%, 55/62 ICMP vs. 20/25 non-ICMP, p=n.s.), involving the interventricular septum in 34/87 (39.1%, 25/62 ICMP vs. 9/25 non-ICMP, p=n.s) and the RVS in 7/87 (8.0%, 5/62 ICMP vs. 2/25 non-ICMP, p=n.s.) patients only. In patients with arrhythmic presentation undergone EAM, substrate map showed abnormal potentials involving the RVS in 4/11 ICMP vs. 1/8 non-ICMP (p=n.s.). Overall, diagnostic sensitivity for RVS sampling was 88.5%: 91.1% vs. 87.8% vs. 83.3% when abnormal CMR/EAM signals were found within interventricular septum (31/34) vs. were found elsewhere (36/41) vs. were absent (10/12), respectively (p=n.s.). Of note, a definite histological diagnosis was obtained in 10/87 patients (11.5%) despite any evidence of LGE or abnormal EAM. Minor complications occurred, since one patient only (1.1%) underwent mild self-limited pericardial effusion. Conclusion: In patients with clinically suspected ICMP, EMB can be performed by sampling just the RVS, allowing for a definite diagnosis in 88.5% of cases. This technique is safe, and shows an acceptable sensitivity even when CMR/EAM shows no local abnormalities or completely normal findings. Background: Up to one third of the patients with myocarditis (MC) have a preserved left ventricular ejection fraction (MCpEF), which remains difficult to diagnose, especially when the patients present in the chronic phase of the disease. Purpose: The purpose of our study was to evaluate the role of adding twodimensional (2D) speckle-tracking echocardiography (STE) to cardiac magnetic resonance imaging (cMRI) in the evaluation of patients with suspected MCpEF and prolonged duration of clinical presentation. Methods: We analyzed 67 patients with suspected chronic MCpEF who underwent endomyocardial biopsies (EMBs). In all patients, 2D STE and cMRI were performed within 48 hours before EMBs. Results: Thirty-two patients with confirmed chronic inflammation served as study group (MCpEF) and the remaining patients (n=35) served as control group. Patients with MCpEF had significantly lower left ventricular global longitudinal systolic strain (GLS) than controls (GLS: -17.01±2.42% vs. -19.39±3.81%, p<0.001). In line, GLS had an adequate diagnostic performance to detect MCpEF (sensitivity, specificity, and accuracy of 82%, 70%, and 76%), which was better than using the current Lake-Louise criteria with cMRI (sensitivity, specificity, and accuracy 54%, 71%, and 67%; respectively). In addition, adding GLS to the Lake-Louise criteria improved significantly the diagnostic performance of cMRI to detect MCpEF (sensitivity, specificity, and accuracy 96%, 55%, and 75%, respectively). Conclusion: 2D STE play a useful role in the current evaluation of patients with suspected chronic myocarditis with preserved left ventricular ejection fraction. Background: One leading cause of heart failure in young adults is the manifestation of a myocarditis. The underlying factors for predisposition towards the development of autoimmune myocarditis are unknown. Mice represent a suitable model to mimic the divergent disease progression observed in humans. Likewise, BALB/c mice are susceptible to the induction of an experimental autoimmune myocarditis (EAM), whereas C57BL/6 mice are not. The identification of molecular targets affecting disease susceptibility is a prerequisite for the identification of novel therapeutic approaches. One of these molecular targets is the interferon stimulated gene of 15 kDa (ISG15). The ISG15 system is crucial for determining susceptibility to the development of chronic viral cardiomyopathy in mice.
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